Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 624 28 2. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112679420B reveals a safe, two-step synthesis of 2,5-dibromopyridine avoiding diazonium salts. Achieves >99.5% purity with reduced wastewater for pharma intermediates.
Eliminate diazonium safety risks with this 80% yield, 99.5% purity process. Reduce wastewater and scale production reliably.